Phenotypic discovery of a pyrimidine derivative with dual anti-prostate cancer and cardioprotective potential via ROS modulation.

Cao Y, Wu Y, Li Y, Li S, Youssif BGM, Du J, Ma L.

Open source

DOI
10.1016/j.bmc.2026.118776
Published
2026-08-13
Container
Bioorg Med Chem
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bmc.2026.118776,
  title = {Phenotypic discovery of a pyrimidine derivative with dual anti-prostate cancer and cardioprotective potential via ROS modulation.},
  author = {Cao Y and  Wu Y and  Li Y and  Li S and  Youssif BGM and  Du J and  Ma L.},
  year = {2026},
  journal = {Bioorg Med Chem},
  doi = {10.1016/j.bmc.2026.118776},
  url = {https://doi.org/10.1016/j.bmc.2026.118776}
}

RIS

TY  - JOUR
TI  - Phenotypic discovery of a pyrimidine derivative with dual anti-prostate cancer and cardioprotective potential via ROS modulation.
AU  - Cao Y
AU  -  Wu Y
AU  -  Li Y
AU  -  Li S
AU  -  Youssif BGM
AU  -  Du J
AU  -  Ma L.
PY  - 2026
JO  - Bioorg Med Chem
DO  - 10.1016/j.bmc.2026.118776
UR  - https://doi.org/10.1016/j.bmc.2026.118776
ER  - 

APA

Y, C., Y, W., Y, L., S, L., BGM, Y., J, D., & L., M. (2026). Phenotypic discovery of a pyrimidine derivative with dual anti-prostate cancer and cardioprotective potential via ROS modulation.. Bioorg Med Chem. https://doi.org/10.1016/j.bmc.2026.118776

Source records